Facebook Pixel “We plan to enter India, Japan, Thailand, and Vietnam to improve the safety of researchers” | BioSpectrum Asia - business - Magzter.comでこの記事を読む
Magzter GOLDで無制限に

Magzter GOLDで無制限に

10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す - 無料

“We plan to enter India, Japan, Thailand, and Vietnam to improve the safety of researchers”

BioSpectrum Asia

|

BioSpectrum Asia August 2025

As biotech research laboratories, in both industry and academic settings, engage in increasingly complex projects worldwide, ensuring the safety of personnel, equipment, and the surrounding environment becomes paramount.

- Dr Manbeena Chawla

“We plan to enter India, Japan, Thailand, and Vietnam to improve the safety of researchers”

Beyond the immediate health impacts, accidents can disrupt the scientific process, leading to data loss, damage to expensive equipment, and significant delays in research progress. Focusing on these critical aspects, South Korea-based startup Connietec has developed innovative solutions that were launched during the recently held ICPI Week 2025 event in South Korea. BioSpectrum Asia spoke with Aden (Seong-Ho) Do, Chief Executive Officer of Connietec, to find out more about the startup's new product line addressing lab safety. Edited excerpts:

Which are the new products launched by Connietec at the ICPI Week 2025?

ConnieTOP, which was released in ICPI Week 2025, is a safety cap system that prevents or purifies fume volatilisation of organic solvents and waste liquid when operating instrument by connecting with analysis instrument such as liquid chromatography that uses a lot of organic solvents such as methanol and acetonitrile, so that it can protect the environment of the laboratory and the health of the researchers and achieve reproducible experimental results.

First, the solvent bottle safety cap (CT-SSC, Solvent Safety Cap) uses a filter designed to prevent the solvent from volatilising out of the solvent bottle when the solvent flows into the analysis instrument, and this filter (CT-CVF12M, Check Valve for 12 Months) applies a PE-based Frit that is different from other companies' membrane filter types, increasing the recommended usage period to about one year compared to six months of other companies’ products, which can be managed at a lower maintenance cost.

BioSpectrum Asia からのその他のストーリー

BioSpectrum Asia

BioSpectrum Asia

India Health Fund supports D-Nome to bolster molecular TB screening in India

India Health Fund (IHF), a Tata Trusts initiative, is poised to transform tuberculosis (TB) screening at scale by enabling the development of the world's most affordable molecular screening tool for TB.

time to read

1 min

BioSpectrum Asia May 2026

BioSpectrum Asia

BioSpectrum Asia

BioOra and Octane Biotech sign LoI to expand cell therapy manufacturing using Cocoon Platform

BioOra, a commercialstage cell therapy company advancing CAR-T therapies for cancer patients, & Canadabased Octane Biotech Inc., an Octane Medical Group Company, has announced the signing of a Letter of Intent (LOI) to collaborate on the co-development & deployment of advanced cell therapies using the Cocoon automated cell therapy manufacturing platform.

time to read

1 min

BioSpectrum Asia May 2026

BioSpectrum Asia

BioSpectrum Asia

NTU and NHG Health partner to advance healthcare education in Singapore

NHG Health's inaugural E3 (Educate, Elevate, Evolve) conference, held recently, was marked by a new partnership with Nanyang Technological University (NTU) Singapore, signalling a significant step in advancing healthcare education through interdisciplinary collaboration.

time to read

1 min

BioSpectrum Asia May 2026

BioSpectrum Asia

Gene Solutions introduces non-invasive prenatal screening technology triSure in Taiwan

Singapore-based startup Gene Solutions has introduced triSure, a revolutionary non-invasive prenatal screening technology.

time to read

1 min

BioSpectrum Asia May 2026

BioSpectrum Asia

How FemTech Spurt in APAC is Redefining Healthcare

Despite representing half the global population, women's health has historically received only a fraction of healthcare innovation and investment.

time to read

4 mins

BioSpectrum Asia May 2026

BioSpectrum Asia

China's Colossal Ageing Population and Low Birth Rate Challenge

China's recent policy initiatives pertaining to long-term care insurance, maternity insurance expansion, and primary healthcare reform reflect a coordinated attempt to address deep structural demographic challenges—most notably 'rapid population ageing' and declining birth rates.

time to read

2 mins

BioSpectrum Asia May 2026

BioSpectrum Asia

"We need to prioritise research as several common AYA cancers are significantly under-studied in Asian populations"

At the SingHealth Presidents' Scientific and Partners in Social-care (SPSOC) Conference, Assistant Professor Eileen Poon, Senior Consultant in Medical Oncology at the National Cancer Centre Singapore (NCCS) delivered an enlightening presentation.

time to read

7 mins

BioSpectrum Asia May 2026

BioSpectrum Asia

Shimadzu Scientific Instruments opens laboratory in San Francisco Bay Area

Shimadzu Scientific Instruments (SSI) has opened its new research and development (R&D) facility in South San Francisco, California, US.

time to read

1 min

BioSpectrum Asia May 2026

BioSpectrum Asia

"Building a lean team with deep operational expertise increases likelihood of success in rare disease drug development"

More than 300 million people worldwide are impacted by over 10,000 rare diseases, i.e. more than cancer and AIDS combined.

time to read

5 mins

BioSpectrum Asia May 2026

BioSpectrum Asia

BioSpectrum Asia

Qiagen expands into bloodstream infection syndromic testing with new rapid QIAstat-Dx panel

Qiagen N.V. has announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel.

time to read

1 min

BioSpectrum Asia May 2026

Listen

Translate

Share

-
+

Change font size